Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2118)	1/15/2008 1:05:56 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CGEN Is up for 2nd day on a roll in spite of the general market.<g> The stock is up 11.94% with volume now 2x its ADV. bigcharts.marketwatch.com As mentioned yesterday, it announced collaboration with MRK, targeted at predicting peptides likely to activate selected GPCRs & validating their agonistic activity. The agreement includes an option to MRK for exclusive worldwide licenses on a peptide by peptide basis,covering the development of therapeutic products. As also mentioned, the stock needs to close above $2.50 <g> bigcharts.marketwatch.com Bernard